Akebia Therapeutics, Inc. (AKBA)
0.5853
-0.03
(-5.31%)
USD |
NASDAQ |
Oct 21, 16:00
0.6069
+0.02
(+3.69%)
After-Hours: 04:06
Akebia Therapeutics Net Income (Annual) : -5.345M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -5.345M |
| December 31, 2024 | -69.41M |
| December 31, 2023 | -51.92M |
| December 31, 2022 | -94.23M |
| December 31, 2021 | -282.02M |
| December 31, 2020 | -383.46M |
| December 31, 2019 | -279.66M |
| December 31, 2018 | -143.59M |
| Date | Value |
|---|---|
| December 31, 2017 | -73.67M |
| December 31, 2016 | -135.75M |
| December 31, 2015 | -60.72M |
| December 31, 2014 | -37.03M |
| December 31, 2013 | -13.17M |
| December 31, 2012 | -8.196M |
| December 31, 2011 | -18.27M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Emergent BioSolutions, Inc. | 52.60M |
| Exelixis, Inc. | 782.57M |
| ADMA Biologics, Inc. | 146.93M |
| Arcutis Biotherapeutics, Inc. | -16.14M |
| Relay Therapeutics, Inc. | -276.48M |